Patent intelligence · US
US 9801954
Lipid substitution on aminoglycoside based polymers: plasmid delivery, anticancer drug delivery and transgene expression
Lipid substitution on aminoglycoside based polymers: plasmid delivery, anticancer drug delivery and transgene expression
Patent details — US 9801954
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 31, 2017
- Expiration
- Oct 26, 2037
- Claims
- 16
- CPC classes
- A61K, A61K47/543, A61K47/59, A61K47/61
Quick answer
US 9801954 (Lipid substitution on aminoglycoside based polymers: plasmid delivery, anticancer drug delivery and transgene expression) is held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY. Status: granted. Granted Oct 31, 2017. Expires Oct 26, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K47/543, A61K47/59, A61K47/61, A61K48/0041
More from ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Related coverage
Frequently asked questions
What is US patent 9801954?
US 9801954 (Lipid substitution on aminoglycoside based polymers: plasmid delivery, anticancer drug delivery and transgene expression) is held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY. Status: granted. Granted Oct 31, 2017. Expires Oct 26, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9801954?
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 9801954 expire?
Our index shows an expiration date of Oct 26, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.